CREG ameliorates embryonic stem cell differentiation into smooth muscle cells by modulation of TGF-β expression

Chengfei Peng1, Xiaoping Shao2, Xiaoxiang Tian1

  • 1Cardiovascular Research Institute and Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.

Insights

Cellular repressor of E1A-stimulated genes (CREG) promotes vascular smooth muscle cell (SMC) differentiation and function. CREG enhances SMC marker expression and contractile capacity via the transforming growth factor-β -smad2/3 pathway.

Area of Science:

  • Cardiovascular Biology
  • Stem Cell Differentiation
  • Molecular Mechanisms

Background:

  • Vascular smooth muscle cell (SMC) differentiation is crucial for cardiovascular development.
  • The precise molecular mechanisms governing SMC differentiation are not fully understood.

Purpose of the Study:

  • To investigate the role and mechanism of cellular repressor of E1A-stimulated genes (CREG) in SMC differentiation.
  • To determine CREG's impact on SMC function and maturation.

Main Methods:

  • Generated embryonic stem cell (ESC) models with CREG overexpression (CREG-OE) and CREG knockout (CREG-KO).
  • Assessed SMC marker expression (e.g., SM α-actin, SM22, Calponin, SM-MHC) during differentiation.
  • Measured calcium ion concentrations and contractile capacity in differentiated SMCs.

Main Results:

  • CREG-OE ESCs showed significantly increased SMC marker levels and contractile capacity.
  • CREG-KO ESCs exhibited decreased SMC marker expression and reduced contractile function.
  • CREG-OE enhanced calcium ion concentrations in stimulated embryoid bodies, while CREG-KO reduced them.

Conclusions:

  • CREG plays a vital role in promoting ESC differentiation into functional SMCs.
  • CREG enhances SMC maturation and contractile function.
  • The transforming growth factor-β -smad2/3 pathway mediates CREG's effects on SMC differentiation and function.